Products

NeuroICH
Neurocareai Inc.
Neurology AI
NeuroICH by Neurocareai Inc. is an FDA-cleared AI tool (K241719) for the rapid detection and notification of intracranial hemorrhages from non-contrast CT scans, designed to improve patient outcomes in critical care.

See all 1 product →

About Neurocareai

NeuroCare.AI is a healthcare AI company that develops AI-based applications for assessing neurological symptoms. For physicians, its platform offers tools to monitor disease progression by measuring, quantifying, and assessing symptoms and side effects, as well as assisting in medication management. The company aims to provide multimodal AI solutions at the edge and cloud, integrating advanced computer vision and large language model (LLM)-driven insights to revolutionize healthcare.

NeuroCare.AI’s product portfolio includes FDA-cleared solutions like NeuroICH™, which enhances diagnostics for cerebral hemorrhage, and RadioViewAI™ and AizaMD™, designed to streamline documentation and improve patient outcomes. The company emphasizes flexible deployment and seamless workflow integration across various platforms (desktop, mobile, cloud) to help providers reduce costs, accelerate decision-making, and expand access to care. Their next-generation tools, such as CXRDetectAI™, DenseViewAI™, and MammoSightAI™, are intended to set new standards for data-driven, quality-focused healthcare.

Focus Areas

AI-based neurological symptom assessment medical imaging cerebral hemorrhage detection brain tumor detection digital health virtual care remote patient monitoring clinical automation LLM-driven insights radiology solutions early breast cancer detection chest X-ray analysis clinical documentation

Business Intelligence

PartnershipsSegmed, Modern Sports Nutrition
TechnologyCloud-native, edge computing, multimodal AI solutions, computer vision, large language models (LLMs), deep learning
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Neurological AI & Assessment
Neurocareai leverages advanced AI for precise neurological symptom assessment, enabling early and accurate detection of critical conditions like cerebral hemorrhage and brain tumors. This specialization aims to enhance diagnostic confidence and expedite treatment pathways for neurological disorders.
Advanced Medical Imaging & Diagnostics
Specializing in comprehensive medical imaging analysis, Neurocareai provides robust radiology solutions, including sophisticated algorithms for early breast cancer detection and efficient chest X-ray analysis. Their technology assists radiologists in identifying subtle anomalies, improving diagnostic throughput and accuracy.
Digital Health & Virtual Care
The company offers a full suite of digital health solutions, encompassing virtual care platforms and remote patient monitoring capabilities. This allows physicians to extend their reach, provide continuous care, and manage patient health proactively, especially for chronic neurological conditions.
AI-driven Clinical Automation & Insights
Neurocareai drives clinical automation to streamline workflows and reduce administrative burden. Utilizing LLM-driven insights, they transform complex clinical data into actionable intelligence and automate clinical documentation, freeing up physician time for direct patient care.
Physician Tip

For physicians considering Neurocareai, focus on how their solutions integrate with your existing EMR/EHR systems to ensure seamless data flow and workflow adoption. Evaluate the clinical validation of their AI models for accuracy and reliability in your specific patient population. Prioritize understanding their data security and privacy protocols (e.g., HIPAA compliance). Assess the ease of use and the level of training and support provided to maximize the benefits of their AI tools in your practice. Consider starting with a pilot program to evaluate the impact on diagnostic efficiency and patient outcomes.

Neurocareai's solutions are designed for seamless integration with existing hospital information systems (HIS), electronic medical records (EMR), and picture archiving and communication systems (PACS) to ensure a unified and efficient clinical workflow. They typically offer robust APIs and adhere to industry standards (e.g., DICOM, HL7) to facilitate interoperability and minimize disruption to current IT infrastructure.

Products by Neurocareai

1 product in the directory

NeuroICH
Neurocareai Inc.
Neurology AI
NeuroICH by Neurocareai Inc. is an FDA-cleared AI tool (K241719) for the rapid detection and notification of intracranial hemorrhages from non-contrast CT scans, designed to improve patient outcomes in critical care.

What the Web Says

Neurocare.ai appears to be a company focused on AI-driven solutions for healthcare, particularly in neurology. While specific product reviews are scarce on major platforms, the company's mission suggests a focus on improving diagnostic and treatment pathways. Employer reviews, if available, would shed light on its internal culture and operational efficiency.

Overall: Mixed

Strengths

  • Focus on AI in healthcare, a growing field
  • Potential to improve neurological diagnostics and treatment
  • Innovative approach to healthcare challenges

Limitations

  • Limited public reviews and detailed product information available on major platforms (G2, Capterra)
  • Scarcity of employer reviews on Glassdoor, making it difficult to assess company culture
  • Specific details about product efficacy and user experience are not readily found
  • Lack of presence on Reddit for community discussions or reviews

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general search)

Last updated: 2026-07-19

Videos

News, demos, and interviews about Neurocareai.

Loading videos...

Videos load interactively. If none appear, search YouTube for Neurocareai →

View all on YouTube

Press & Coverage

Signalbase
NeuroCare.AI Secures $20.8M Funding Boost to Accelerate AI-Driven Healthcare Innovation
NeuroCare.AI announced a $20.8 million funding round to advance its AI-driven healthcare solutions, including AizaMD for clinical documentation, Radiology Report Generation (RRG), RadioView.AI for mobile DICOM image access, and NeuroICH for early stroke detection. The funding will support research, development, and global expansion of their HIPAA-compliant and HiTrust certified products.
2025-02
accessdata.fda.gov
Neurocareai Inc. Junaid Siddiq Kalia Chief Executive Officer 8992 Preston Rd Ste 110-255 Frisco, Texas 75034 Re - accessdata.fda.gov
This FDA document from November 2024 addresses Neurocareai Inc.'s compliance with Unique Device Identification System (UDI) rules for medical devices, specifically mentioning their NeuroICH device. It outlines requirements for labeling, good manufacturing practice, and reporting, and describes NeuroICH as a notification-only tool for identifying suspected intracranial hemorrhage.
2024-11
Andru00e9ia Pereira (Blog/Publication)
Driving AI-Powered Healthcare Innovation: How Segmed Helped NeuroCare.AI Achieve Success | Andru00e9ia Pereira
This article highlights how Segmed's de-identified datasets accelerated NeuroCare.AI's R&D and FDA approval for its NeuroICHu2122 device, which detects cerebral hemorrhage. Segmed's data solutions ensured compliance and provided diverse medical imaging data, crucial for developing robust AI models.
unknown
IHIE.IO - Institute of Health Innovation & Education
Revolutionizing AI-Based Stroke Care - IHIE.IO - Institute of Health Innovation & Education
The Institute of Health Innovation and Education, in partnership with NeuroCareAI, is deploying the NeuroICH AI Model for free in Low- and Middle-Income Countries (LMICs) to revolutionize stroke care. The initiative aims to save lives and reduce healthcare costs by facilitating early stroke detection and rapid diagnosis of intracranial hemorrhage.
unknown
PMC (PubMed Central)
Systematic review of commercial artificial intelligence tools for the detection and volume quantification in intracerebral hemorrhage - PMC
A systematic review published in July 2025 includes Neurocareai Inc. and its NeuroICH product among commercial AI tools for intracerebral hemorrhage detection and volume quantification. The review notes Neurocareai Inc.'s FDA 510(K) Class II clearance for ICH detection and triage function.
2025-07
PubMed
Revolutionizing Acute Stroke Care: A Review of Food and Drug Administration-Approved Software as Medical Devices for Stroke Triage - PubMed
This review article, published in November 2024, explores FDA-approved AI and machine learning software as medical devices for stroke triaging, with an affiliation listed for NeuroCareAI. It highlights their impact on reducing notification times and improving patient outcomes.
2024-11
ResearchGate
Patient-Reported Outcome Measures (PROMs) in Neurology for Web 3.0 and mHealth: A Conceptual Framework - ResearchGate
A conceptual framework for Patient-Reported Outcome Measures (PROMs) in Neurology for Web 3.0 and mHealth, co-authored by individuals from NeuroCareAI, was published in January 2024. The article proposes a framework for easily customizable electronic PROMs (ePROMs) in neurology to improve patient care and data collection.
2024-01
YouTube (NeuroCareAI Channel)
Moral Injury & Women in Medicine - YouTube
A YouTube video from December 2022 features Junaid Kalia, founder of NeuroCareAI, discussing moral injury and burnout in medicine. This content is part of a course on choosing a medical specialty in the digital healthcare era.
2022-12

Frequently Asked Questions

Neurocareai provides several AI-powered tools for neurological diagnostics, including NeuroICHu2122, an FDA-cleared solution for detecting cerebral hemorrhage and facilitating rapid access to neuroimaging. Additionally, they offer an AI tool for brain tumor detection from medical scans, boasting 97.5% accuracy and instant analysis of MRI/CT scans.
Beyond neurology, Neurocareai extends its AI capabilities to general radiology with products like CXRDetectAIu2122 for chest X-ray analysis and MammoSightAIu2122 for early breast cancer detection. They also offer DenseViewAIu2122, which likely relates to breast imaging, aiming to set new standards for data-driven healthcare.
Neurocareai emphasizes multimodal AI solutions deployable across desktop, mobile, and cloud environments, supporting digital health and virtual care. Their platform includes features like patient transparency apps and doctor-patient support through video calls and chats, aligning with remote patient monitoring principles.
Neurocareai integrates advanced computer vision and LLM-driven insights to revolutionize healthcare, particularly in clinical automation. Their products, such as RadioViewAIu2122 and AizaMDu2122, are designed to streamline documentation processes and improve patient outcomes by providing data-driven support.
Neurocareai states that its models are HIPAA & GDPR Compliant, ensuring patient data privacy and security. Their NeuroICHu2122 product is FDA-cleared, indicating adherence to stringent regulatory standards for medical devices.
Neurocareai has partnered with Segmed to access high-quality, de-identified medical imaging datasets, which significantly accelerated their model development and FDA approval processes. The company, also known as SaveLife.AI, is founded by Junaid Kalia, MD, a specialist in neurocritical care, suggesting strong leadership and a focus on innovation.
While specific pricing details are not extensively publicized, Neurocareai mentions offering flexible pricing plans. They aim for a user-friendly web interface that requires no extensive training and provide doctor-patient support features, including video calls and personalized recovery plans, to assist healthcare providers.

Related Companies

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.